Comprehensive Limb Evaluation and Arterial Revascularization With Toe Pressure Optimization Registry
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Bordeaux
- Trial code
- NCT07014072
- Record updated
- 10 June 2025
- Original description
To address the heterogeneity of practices, better understand the outcomes of cricital limb theatening ischemia (CLTI) patients after endovascular interventions, and recognize effective endovascular options for infrapopliteal artery revascularization in CLTI, our prospective registry aims to tackle the critical question of whether intensive toe pressure evaluation, guiding repeat revascularization using predetermined thresholds (<30 mmHg or decrease >10% from immediate postoperative assessment), could optimize outcomes in patients with CLTI.Read full original descriptionShow less
To address the heterogeneity of practices, better understand the outcomes of cricital limb theatening ischemia (CLTI) patients after endovascular interventions, and recognize effective endovascular options for infrapopliteal artery revascularization in CLTI, our prospective registry aims to tackle the critical question of whether intensive toe pressure evaluation, guiding repeat revascularization using predetermined thresholds (<30 mmHg or decrease >10% from immediate postoperative assessment), could optimize outcomes in patients with CLTI.
Inclusion: Age ≥ 18 years; Rutherford category 4 or 5; Wounds limited to toes or forefoot with a salvageable limb; Infrapopliteal lesions (infra-popliteal arteries) with >70% stenosis upon visual assessment during initial angiography.
Exclusion: Previous or planned major amputation of the target limb; Untreated aortoiliac/femoropopliteal stenotic disease limiting flow; History of infrapopliteal bypass on the target limb; Failure of percutaneous transluminal angioplasty of the target limb (technical failure); Absence of angiographic evidence of a patent artery below the ankle ("desert foot"); Lesions located inside or near an arterial aneurysm; Life expectancy < 1 year; Acute limb ischemia; Septicemia or bacteremia.